Although Blk is regarded as a tumor suppressor, in CML LSCs, via upregulation of p27, BCR-ABL1 downsizes the expression of this protein by modulation of c-myc and Pax5. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.